Page last updated: 2024-10-25

cycloleucine and Multiple Myeloma

cycloleucine has been researched along with Multiple Myeloma in 6 studies

Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BERGSAGEL, DE2
ROSS, SW1
BAKER, DT1
HAYES, DM1
SPURR, CL1
MASS, RE1
HELSPER, JT1
SHARP, GS1
BENEFIEL, WW1
KRANT, MJ1
ISZARD, DM1
ABADI, A1
CAREY, RW1

Other Studies

6 other studies available for cycloleucine and Multiple Myeloma

ArticleYear
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    Cancer chemotherapy reports, 1962, Volume: 21

    Topics: Antineoplastic Agents; Cell- and Tissue-Based Therapy; Cycloleucine; Cycloparaffins; Multiple Myelom

1962
Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    Cancer chemotherapy reports, 1962, Volume: 16

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell- and Tissue-Based Therapy; Cycloleucine; Cyclopar

1962
The effect of 1-aminocyclopentane carboxylic acid (NSC-1026) on mouse plasmacytoma.
    Cancer chemotherapy reports, 1961, Volume: 14

    Topics: Antineoplastic Agents; Carboxylic Acids; Cycloleucine; Cycloparaffins; Multiple Myeloma; Plasma Cell

1961
Clinical evaluation of 1-aminocyclopentanecarboxylic acid (NSC-1026) in plasmocytic myeloma.
    Cancer chemotherapy reports, 1963, Volume: 28

    Topics: Antineoplastic Agents; Cycloleucine; Cycloparaffins; Multiple Myeloma

1963
THE TREATMENT OF MULTIPLE MYELOMA WITH 1-AMINOCYCLOPENTANECARBOXYLIC ACID.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Antineoplastic Agents; Blood Protein Electrophoresis; Cycloleucine; Cycloparaffins; gamma-Globulins;

1964
Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).
    Cancer chemotherapy reports, 1962, Volume: 22

    Topics: Amino Acids; Antifibrinolytic Agents; Cell- and Tissue-Based Therapy; Cycloleucine; Cycloparaffins;

1962